D. E. Shaw & Co., Inc. Imara Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $96,445 - $202,117	-83,866 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.05 $49,218 - $88,593	21,875 Added 35.29%	83,866 $189,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $252,923 - $485,389	61,991 New	61,991 $253,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.